Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick O'Toole

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Pediatric Orthopedics|March 5, 2024
Functional Outcomes of Congenital Scoliosis at a Mean 35-Year Follow-up Post In Situ Fusion. Revisiting Patients From the 2002 Goldberg et al StudyMartin J Kelly, Flavia Alberghina, Patrick McCabe, et al.
The Journal of Arthroplasty|December 24, 2013
Oral antibiotic therapyPatrick O'Toole, Douglas Osmon, Alex Soriano, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|January 28, 2014
Oral antibiotic therapyPatrick O'Toole, Douglas Osmon, Alex Soriano, et al.
Cancer Cell|November 1, 2024
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trialDiwakar Davar, Robert M Morrison, Amiran K Dzutsev, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Pediatric Orthopedics|March 5, 2024
Functional Outcomes of Congenital Scoliosis at a Mean 35-Year Follow-up Post In Situ Fusion. Revisiting Patients From the 2002 Goldberg et al StudyMartin J Kelly, Flavia Alberghina, Patrick McCabe, et al.
The Journal of Arthroplasty|December 24, 2013
Oral antibiotic therapyPatrick O'Toole, Douglas Osmon, Alex Soriano, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|January 28, 2014
Oral antibiotic therapyPatrick O'Toole, Douglas Osmon, Alex Soriano, et al.
Cancer Cell|November 1, 2024
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trialDiwakar Davar, Robert M Morrison, Amiran K Dzutsev, et al.
Pageof 3